BRT in the treatment of diabetes mellitus

AUTHORS : Gustomesova E.N. | Deeva T.S. | Gustomesova V.I.

RELEVANT UNIVERSITIES : Voronezh State Medical Academy named after N.N.Burdenko, Regional Clinical Hospital, Voronezh,Russia

YEAR : 2004 | Category : Type of Application

Diabetes mellitus is one of the pressing health problems. The number of patients with diabetes, according to WHO, currently exceeds 160 million people and continues to progressively increase. Its prevalence, especially in industrially developed countries, reaches 6%, in the Russian Federation – 5%. Sugar diabetes – This Group metabolic diseases, characterized by the presence of hyperglycemia following defect insulin secretion, a defect in its action at the cell level, or both.

Chronic hyperglycemia over time leads to dysfunction and irreversible damage to various systems and organs, primarily the eyes, kidneys, nerves, etc. All this contributes to early disability and mortality, which is due to the presence of late vascular complications of diabetes: microangiopathy (retinopathy, nephropathy), macroangiopathy (myocardial infarction, stroke, gangrene of the lower extremities), neuropathy.

The way to solve the problem is to identify and treat the initial stages of the disease, and to achieve stable compensation. Long-term compensation of carbohydrate metabolism significantly reduces the incidence of complications of diabetes mellitus.

Criteria for compensation of type 1 diabetes mellitus:

– fasting blood glucose and before meals – 5.1–6.5 mmol / l;

– blood glucose 2 hours after a meal – 7.6-9.0 mmol / l;

– triglycerides – less than 1.7 mmol / l;

– cholesterol – less than 4.8 mmol / l;

– blood pressure – less than 135/85 mm. rt. Art. Criteria